Skip to content

A follow-up study of novel coronavirus pneumonia (COVID-19) patients in Wanzhou District, Chongqing

A follow-up study of novel coronavirus pneumonia (COVID-19) patients in Wanzhou District, Chongqing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033980
Enrollment
Unknown
Registered
2020-06-19
Start date
2020-06-10
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:none

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1. History of epidemiology: (1) Travel history or residence history of Wuhan City and surrounding areas, or other communities with case reports within 14 days before the onset of illness; (2) History of contact with new coronavirus infection (nucleic acid test positive) within 14 days before onset of illness; (3) Have contacted patients with fever or respiratory symptoms from Wuhan City and surrounding areas, or from communities with reported cases within 14 days before the onset of illness; (4) Aggregated onset (in a small area such as home, office, school within 2 weeks) Classes and other places, there are 2 or more cases of fever and/or respiratory symptoms). 2. Clinical manifestations: (1) Fever and/or respiratory symptoms; (2) Imaging characteristics of pneumonia; (3) The total number of white blood cells in the early stage of the disease is normal or decreased, and the lymphocyte count is normal or decreased. 3. Etiology or serology basis: (1) Real-time fluorescent RT-PCR detection of positive coronavirus nucleic acid; (2) Viral gene sequencing, highly homologous to known new coronavirus; (3) Serum positive coronavirus-specific IgM and IgG antibodies; serum The new coronavirus-specific IgG antibody changed from negative to positive or the recovery period was more than 4 times higher than the acute period. Have any one of the epidemiological history, plus any 2 of the clinical manifestations, plus any one of the etiology or serology basis; or no epidemiological history, meet all 3 of the clinical manifestations, plus the etiology or serology basis Any one of them can diagnose a new coronavirus pneumonia infection.

Exclusion criteria

Exclusion criteria: Those who cannot follow up regularly or who cannot cooperate with the investigator

Design outcomes

Primary

MeasureTime frame
chest CT;pulmonary function;viral nucleic acid test;Blood routine test;liver and kidney function;

Countries

China

Contacts

Public ContactDepeng Jiang

The Second Affiliated Hospital of Chongqing Medical University

depengjiang@163.com+86 1592266878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026